Changes in practice patterns affecting in-hospital and post-discharge survival among ACS patients

Table 2 Mortality Hazard During Stay at Index Hospital by Patient Characteristics, Treatments and Time Cohort (n = 1,972)

Variables:	Hazard Ratios	95% CI	p-value	Δχ²-value
Age	1.01	0.99–1.02	>0.28	1.16
Gender (male)*	0.78	0.55–1.10	>0.16	2.01
Race (white)*	1.16	0.73–1.87	>0.53	0.40
Charlson Index***	2.03	1.43–2.88	<0.01	15.69
Ejection Fraction (<35%)*				8.71**
35%–44%	0.96	0.46–2.03	>0.92	0.01
≥45%	0.38	0.18–0.82	<0.01	6.15
missing	1.00	0.57–1.77	>0.99	<0.01
Invasive Procedures (none)*				23.01**
CATH	0.31	0.17–0.58	<0.01	13.56
PCI	0.42	0.23–0.79	<0.01	7.21
CABG	0.19	0.08–0.47	<0.01	13.12
ACEIs & ARBs – in hospital	0.44	0.31–0.64	<0.01	18.66
Beta Blockers – in hospital	0.73	0.48–1.10	>0.13	2.31
Aspirin – in hospital	0.49	0.33–0.71	<0.01	13.87
Thrombolytics – in hospital	0.57	0.39–0.83	<0.01	8.51
Time Cohorts (MICH1)*				16.95**
MICH2	1.46	0.99–2.15	>0.05	3.57
HARP	0.16	0.05–0.46	<0.01	11.48

ISSN: 1472-6963